I followed your steps, read the metrics and ARI-vs-size CSVs, checked Procrustes disparities, and briefly inspected the regenerated UMAPs to align quantitative and visual patterns. I saved a concise, 15–25 line biological interpretation here:
/home/erwinpi/pantheon-agents/examples/gene_panel_selection/cases/kidney/workdir/selection_expert/results/biologist_interpretation.md

Summary of key points captured in the file:
- SpaPROS attains the highest ARI and often top NMI across splits, though with more variability; DE is consistently second-best and very stable; RF is competitive.
- The curated Final panel is solid and typically outperforms HVG and the Full reference on ARI/NMI; scGeneFit underperforms markedly.
- ARI vs panel size shows RF best at very small sizes, DE peaking at ~300–400 genes, SpaPROS good across 200–700 genes; HVG modest; scGeneFit near zero.
- Procrustes: RF and DE best preserve Full topology; Final moderate; SpaPROS less faithful; HVG and scGeneFit diverge most.
- UMAPs agree: DE, RF, Final show clean separation and resemblance to Full; HVG rearranged; scGeneFit mixed.
- Biologically, the curated Final panel includes immune/tumor/stromal/vascular markers expected to resolve RCC tumor microenvironment, supporting its balance between accuracy, stability, and interpretability.